Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10494309rdf:typepubmed:Citationlld:pubmed
pubmed-article:10494309lifeskim:mentionsumls-concept:C0011849lld:lifeskim
pubmed-article:10494309lifeskim:mentionsumls-concept:C0017319lld:lifeskim
pubmed-article:10494309lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:10494309lifeskim:mentionsumls-concept:C1706244lld:lifeskim
pubmed-article:10494309lifeskim:mentionsumls-concept:C0439617lld:lifeskim
pubmed-article:10494309lifeskim:mentionsumls-concept:C0557806lld:lifeskim
pubmed-article:10494309lifeskim:mentionsumls-concept:C0936005lld:lifeskim
pubmed-article:10494309lifeskim:mentionsumls-concept:C0013331lld:lifeskim
pubmed-article:10494309pubmed:issue33lld:pubmed
pubmed-article:10494309pubmed:dateCreated1999-10-21lld:pubmed
pubmed-article:10494309pubmed:abstractTextThe main changes of the first revision of the guideline of the Dutch College of General Practitioners on the diagnosis and treatment of diabetes mellitus type 2 compared with the first edition concern the following aspects: more attention is given to organisation and management of diabetes care; new diagnostic criteria for diabetes are introduced; guidelines are given for the early detection of diabetes in high risk groups; the distinction between sulfonylureas of the first and the second generation has been dropped; in the treatment of patients with diabetes and a body mass index > 27 metformin is the drug of first choice; optional guidelines are given for the treatment with insulin; guidelines are given for the treatment of hypertension and hypercholesterolaemia in patients with diabetes.lld:pubmed
pubmed-article:10494309pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10494309pubmed:languagedutlld:pubmed
pubmed-article:10494309pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10494309pubmed:citationSubsetIMlld:pubmed
pubmed-article:10494309pubmed:statusMEDLINElld:pubmed
pubmed-article:10494309pubmed:monthAuglld:pubmed
pubmed-article:10494309pubmed:issn0028-2162lld:pubmed
pubmed-article:10494309pubmed:authorpubmed-author:HeineR JRJlld:pubmed
pubmed-article:10494309pubmed:authorpubmed-author:RuttenG EGElld:pubmed
pubmed-article:10494309pubmed:authorpubmed-author:WiersmaT JTJlld:pubmed
pubmed-article:10494309pubmed:issnTypePrintlld:pubmed
pubmed-article:10494309pubmed:day14lld:pubmed
pubmed-article:10494309pubmed:volume143lld:pubmed
pubmed-article:10494309pubmed:ownerNLMlld:pubmed
pubmed-article:10494309pubmed:authorsCompleteYlld:pubmed
pubmed-article:10494309pubmed:pagination1688-91lld:pubmed
pubmed-article:10494309pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10494309pubmed:meshHeadingpubmed-meshheading:10494309...lld:pubmed
pubmed-article:10494309pubmed:meshHeadingpubmed-meshheading:10494309...lld:pubmed
pubmed-article:10494309pubmed:year1999lld:pubmed
pubmed-article:10494309pubmed:articleTitle[Summary of the practice guideline 'Diabetes mellitus type 2' (first revision) of the Dutch College of General Practitioners].lld:pubmed
pubmed-article:10494309pubmed:affiliationAfd. Standaardenontwikkeling, Nederlands Huisartsen Genootschap, Utrecht.lld:pubmed
pubmed-article:10494309pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10494309pubmed:publicationTypeGuidelinelld:pubmed
pubmed-article:10494309pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:10494309pubmed:publicationTypePractice Guidelinelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10494309lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10494309lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10494309lld:pubmed